Gut Garden

Program Highlights

Research

Interested in collaborating?

Trial #1

Group, Location

Link to trial

More information regarding the trial and who it is meant for

Trial #2

Group, Location

Link to trial

More information regarding the trial and who it is meant for

Trial #3

Group, Location

Link to trial

More information regarding the trial and who it is meant for

Trial #4

Group, Location

Link to trial

More information regarding the trial and who it is meant for

SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection

In patients with symptom resolution of C. difficile infection after treatment with standard-of-care antibiotics, oral administration of...

Ethical considerations in microbial therapeutic clinical trials

As understanding of the human microbiome improves, novel therapeutic targets to improve human health with microbial therapeutics will...

Tacrolimus concentration to dose ratio in solid organ transplant patients treated with FMT for RCDI

Fecal microbiota transplantation (FMT) is increasingly being performed for Clostridium difficile infection in solid organ transplant...

Durability and Long-term Clinical Outcomes of FMT Treatment in Patients with Recurrent CDI

Fecal microbiota transplant (FMT) appears safe and effective for treatment of recurrent Clostridium difficile infection (RCDI). However,...

Risk factors & epidemiology of CDI in HSCT recipients recipients during the peritransplant period

Hematopoietic stem cell transplant (HSCT) recipients represent a high- risk group for developing Clostridium difficile infection (CDI). ...

FMT for Refractory Clostridium difficile Colitis in Solid Organ Transplant Recipients

Fecal microbiota transplantation (FMT) has been shown to be safe and efficacious in individuals with refractory Clostridium difficile. It...

Fecal Microbiota Transplant for CDI in a Pregnant Patient

Clostridium difficile infection has been associated with negative outcomes in the general population and in pregnant patients. Fecal...

FMT for the treatment of recurrent and severe CDI in solid organ transplant recipients

Fecal microbiota transplant (FMT) is recommended for Clostridium difficile infection (CDI) treatment; however, use in solid organ...

FMT for Refractory CDI Interrupts 25-Year History of Recurrent Urinary Tract Infections

An 83-year-old female had a 25-year history of recurrent urinary tract infections (UTIs) presented to our infectious disease clinic with...

FMT for Multidrug-Resistant Organism Decolonization Administered During Septic Shock

Antibiotic resistance is a growing emergency due to globalization and widespread antibiotic use. New antibiotics are not being developed...

Fecal microbiota transplant for Clostridium difficile infection in older adults